“Sulindac Metabolites Inhibit Epidermal Growth Factor Receptor Activation and Expression”. Journal of Carcinogenesis 4, no. 1 (October 28, 2005). Accessed December 6, 2025. https://carcinogenesis.com/index.php/JOC/article/view/262.